Politics
Get politics news, features and expert analysis from Kiplinger. Find out how what happens on the Hill affect your budget.
Latest
-
Changes to Estate Tax Are Coming... Six Options Congress Could Take
The Tax Letter An important estate tax change is looming. Here are six ways that Congress might address estate taxes in 2025.
By Joy Taylor Published
The Tax Letter -
What Investors Should Keep in Mind This Election Season
Don’t let the political fearmongering derail you from your financial plan.
By Mario Hernandez Last updated
-
How Will the 2024 Election Affect Your Retirement?
Investors should expect volatility but also try not to overreact to news. To prepare, focus now on tax minimization, protecting your portfolio and more.
By Barry H. Spencer, Registered Investment Adviser Last updated
-
How Trump and Harris Might Handle Expiring TCJA Tax Cuts
Election 2024 Many key provisions of the TCJA will expire soon. Here’s why it matters during the 2024 election cycle.
By Gabriella Cruz-Martínez Last updated
Election 2024 -
The 2024 Presidential Election is a Close Race So Far...
The Kiplinger Letter Two months out, presidential candidates, Harris and Trump are neck and neck. An early look at the election picture.
By Matthew Housiaux Published
The Kiplinger Letter -
What Will the Stock Market Do as Election Nears?
Despite the presidential election’s domination of the headlines, economic and inflation trends have consistently outweighed electoral outcomes in the past.
By Adam Lampe Last updated
-
Here Are the 10 Medicare Negotiated Drug Prices
Medicare announced the negotiated prices for 10 drugs, which are among the costliest and most used.
By Alexandra Svokos Published
-
Harris Said She'd Ban Corporate Price Gouging. What Does That Mean?
Kamala Harris said she would support a federal ban on corporate price gouging on food and groceries as president. What does that mean?
By Erin Bendig Last updated
-
Biden-Harris: Price Cuts on 10 Drugs to Save Medicare Beneficiaries $1.5 Billion
Historic Medicare drug price negotiations are said to lower costs on 10 best-selling drugs, saving Medicare beneficiaries $1.5 billion in out-of-pocket costs in the program's first year.
By Kathryn Pomroy Last updated